A virtual format will enable innovative learning opportunities, increased schedule flexibility, and a new level of interaction between regulatory practitioners, industry experts, and government officials. Speakers will analyze the latest commercial issues related to advertising and promotion of human and animal drugs, medical devices, and biologics
Practical Takeaways: Sessions will explore updated government agency initiatives, goals, and priorities, product promotion in a remote environment, social media best practices, trends in pre- approval communications, effective patient engagement, and litigation risks.
Government Speakers: Representatives from various FDA Centers, the Federal Trade Commission, the Department of Health and Human Services Inspector General, and the Department of Justice will provide the latest information on policy, enforcement, and future initiatives.
Peer Interaction: The conference will prioritize virtual learning, engagement, and networking with fellow legal, regulatory, and marketing experts.